Brief: Affluent Medical End-June Net Loss Widens To EUR 8.2 Mln
28/09/2022 17:42
Sept 28 (Reuters) - AFFLUENT MEDICAL SAS AFME.PA :
* AFFLUENT MEDICAL: FINANCIAL RESULTS FOR H1 2022 AND
SIGNIFICANT
PROGRESSES IN 2022
* APPOINTMENT OF SÉBASTIEN LADET, WHO LEAVES MEDTRONIC TO
AFFLUENT
MEDICAL, AS CHIEF EXECUTIVE OFFICER
* END-JUNE CURRENT OPERATING LOSS EUR 7.3 MILLION VERSUS
LOSS EUR
7.4 MILLION YEAR AGO
* END-JUNE NET LOSS EUR 8.2 MILLION VERSUS LOSS EUR 7.6
MILLION
YEAR AGO
* END-JUNE CASH AND CASH EQUIVALENTS AT EUR 3.4 MILLION
VERSUS EUR
20.1 MILLION YEAR AGO
* IN COMING WEEKS, AFFLUENT MEDICAL PLANS TO INCREASE NUMBER
OF
CLINICAL INVESTIGATION CENTERS FROM 4 TO 9 WITH A GOAL OF 11
CENTERS DURING 2023
Source text for Eikon: ID:nEQb4Thswa
Further company coverage: AFME.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587 696 600;))
Recent news on Carvolix SA
See all newsBrief: Affluent Medical/Artus: Achieves Clinical Objective Of Dry Pilot Study In First Two Patients
Brief: Affluent Medical Announces Successful First-In-Human Implantation Of Its Artificial Sphincter Artus For The Treatment Of Stress Urinary Incontinence
Brief: Affluent Medical Closes Bridge Of 3.5 Million Euros Via Capital Increase From Key Shareholders
Brief: Affluent Medical H1 Operating Loss EUR 7.4 Mln
Brief: Affluent Medical Announces Positive Clinical 1-Yr Results For Kalios